Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
3.020
-0.120 (-3.82%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182012 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2012 - 2017
Gene Therapeutics
1.00M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182012 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2012 - 2017
United States
1.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade